RxSight annual depreciation and amortization
2020
2021
2022
2023
2024
2025
RxSight Depreciation & Amortization Growth & History (RXST)
RxSight's depreciation and amortization was $3.3M for fiscal 2025.
View full RxSight company overviewRxSight annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.3M | −$309,000 | −8.64% |
| 2024 | 2024-12-31 | $3.6M | −$503,000 | −12.33% |
| 2023 | 2023-12-31 | $4.1M | $194,000 | +4.99% |
| 2022 | 2022-12-31 | $3.9M | −$91,000 | −2.29% |
| 2021 | 2021-12-31 | $4.0M | $122,000 | +3.17% |
| 2020 | 2020-12-31 | $3.9M | — | — |
RxSight quarterly depreciation and amortization
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $999,000 | $214,000 | +27.26% |
| Q1 2026 | 2026-03-31 | $834,000 | $58,000 | +7.47% |
| Q4 2025 | 2025-12-31 | $851,000 | — | — |
| Q3 2025 | 2025-09-30 | $854,000 | −$279,000 | −24.62% |
| Q2 2025 | 2025-06-30 | $785,000 | −$27,000 | −3.33% |
| Q1 2025 | 2025-03-31 | $776,000 | −$339,000 | −30.40% |
| Q3 2024 | 2024-09-30 | $1.1M | $50,000 | +4.62% |
| Q2 2024 | 2024-06-30 | $812,000 | −$177,000 | −17.90% |
| Q1 2024 | 2024-03-31 | $1.1M | $160,000 | +16.75% |
| Q3 2023 | 2023-09-30 | $1.1M | $142,000 | +15.09% |
| Q2 2023 | 2023-06-30 | $989,000 | −$20,000 | −1.98% |
| Q1 2023 | 2023-03-31 | $955,000 | −$61,000 | −6.00% |
| Q3 2022 | 2022-09-30 | $941,000 | −$65,000 | −6.46% |
| Q2 2022 | 2022-06-30 | $1.0M | $23,000 | +2.33% |
| Q1 2022 | 2022-03-31 | $1.0M | $58,000 | +6.05% |
| Q3 2021 | 2021-09-30 | $1.0M | −$28,000 | −2.71% |
| Q2 2021 | 2021-06-30 | $986,000 | — | — |
| Q1 2021 | 2021-03-31 | $958,000 | — | — |
| Q3 2020 | 2020-09-30 | $1.0M | — | — |
RxSight depreciation and amortization trends
Over the last five fiscal years, RxSight's depreciation and amortization decreased from $3.9M to $3.3M, a change of −$587,000. The latest reported quarter, Q2 2026, shows $999,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RxSight source filings ↗